783 related articles for article (PubMed ID: 11308434)
1. Effectiveness of St John's wort in major depression: a randomized controlled trial.
Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U
JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434
[TBL] [Abstract][Full Text] [Related]
2. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
Fava M; Alpert J; Nierenberg AA; Mischoulon D; Otto MW; Zajecka J; Murck H; Rosenbaum JF
J Clin Psychopharmacol; 2005 Oct; 25(5):441-7. PubMed ID: 16160619
[TBL] [Abstract][Full Text] [Related]
3. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
; Davidson JR; Gadde KM; Fairbank JA; Krishnan KRR; Califf RM; Binanay C; Parker CB; Pugh N; Hartwell TD; Vitiello B; Ritz L; Severe J; Cole JO; de Battista C; Doraiswamy PM; Feighner JP; Keck P; Kelsey J; Lin KM; Londborg PD; Nemeroff CB; Schatzberg AF; Sheehan DV; Srivastava RK; Taylor L; Trivedi MH; Weisler RH
JAMA; 2002 Apr; 287(14):1807-14. PubMed ID: 11939866
[TBL] [Abstract][Full Text] [Related]
4. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M
BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
Gelenberg AJ; Shelton RC; Crits-Christoph P; Keller MB; Dunner DL; Hirschfeld RM; Thase ME; Russell JM; Lydiard RB; Gallop RJ; Todd L; Hellerstein DJ; Goodnick PJ; Keitner GI; Stahl SM; Halbreich U; Hopkins HS
J Clin Psychiatry; 2004 Aug; 65(8):1114-9. PubMed ID: 15323598
[TBL] [Abstract][Full Text] [Related]
6. An open-label pilot study of St. John's wort in juvenile depression.
Findling RL; McNamara NK; O'Riordan MA; Reed MD; Demeter CA; Branicky LA; Blumer JL
J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):908-14. PubMed ID: 12874492
[TBL] [Abstract][Full Text] [Related]
7. St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study.
Kobak KA; Taylor LV; Bystritsky A; Kohlenberg CJ; Greist JH; Tucker P; Warner G; Futterer R; Vapnik T
Int Clin Psychopharmacol; 2005 Nov; 20(6):299-304. PubMed ID: 16192837
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
Randløv C; Mehlsen J; Thomsen CF; Hedman C; von Fircks H; Winther K
Phytomedicine; 2006 Mar; 13(4):215-21. PubMed ID: 16423519
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
Lecrubier Y; Clerc G; Didi R; Kieser M
Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
[TBL] [Abstract][Full Text] [Related]
10. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
Mannel M; Kuhn U; Schmidt U; Ploch M; Murck H
J Psychiatr Res; 2010 Sep; 44(12):760-7. PubMed ID: 20181361
[TBL] [Abstract][Full Text] [Related]
11. St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT.
Sarris J; Fava M; Schweitzer I; Mischoulon D
Pharmacopsychiatry; 2012 Nov; 45(7):275-8. PubMed ID: 22592504
[TBL] [Abstract][Full Text] [Related]
12. [Use of St. John's Wort for depression in primary care - a non-interventional study].
Musselmann B; Rychlik R; Burkart M
MMW Fortschr Med; 2011 Dec; 153 Suppl 4():119-27. PubMed ID: 23964473
[TBL] [Abstract][Full Text] [Related]
13. Effect of St John's wort on severity, frequency, and duration of hot flashes in premenopausal, perimenopausal and postmenopausal women: a randomized, double-blind, placebo-controlled study.
Abdali K; Khajehei M; Tabatabaee HR
Menopause; 2010 Mar; 17(2):326-31. PubMed ID: 20216274
[TBL] [Abstract][Full Text] [Related]
14. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
[TBL] [Abstract][Full Text] [Related]
15. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Laakmann G; Schüle C; Baghai T; Kieser M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
[TBL] [Abstract][Full Text] [Related]
16. St John's wort or sertraline? Randomized controlled trial in primary care.
van Gurp G; Meterissian GB; Haiek LN; McCusker J; Bellavance F
Can Fam Physician; 2002 May; 48():905-12. PubMed ID: 12053635
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
Ng QX; Venkatanarayanan N; Ho CY
J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
[TBL] [Abstract][Full Text] [Related]
18. Comparison of St John's wort and imipramine for treating depression: randomised controlled trial.
Woelk H
BMJ; 2000 Sep; 321(7260):536-9. PubMed ID: 10968813
[TBL] [Abstract][Full Text] [Related]
19. Potential treatment for subthreshold and mild depression: a comparison of St. John's wort extracts and fluoxetine.
Volz HP; Laux P
Compr Psychiatry; 2000; 41(2 Suppl 1):133-7. PubMed ID: 10746915
[TBL] [Abstract][Full Text] [Related]
20. St John's wort (Hypericum perforatum) in major depression.
Shelton RC
J Clin Psychiatry; 2009; 70 Suppl 5():23-7. PubMed ID: 19909690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
